✦ LIBER ✦

PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATES

✍ Scribed by R.F. Pollock; B. Curtis; K.S. Boye; L. Timlin; W.J. Valentine

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PDB28 COST SAVINGS IN TYPE-2 DIABETES (T

✍ C. Tilling; L.M. Evans; M. Keech 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PDB41 INSULIN AND INSULIN ANCILLARY USAG

✍ F Chandler; PD Ambery; K De Silva; PJ Mulley 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMI

✍ S. Curkendall; B. Zhang; K. Oh; S. Williams; M. Pollack; J.P. Graham 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

DB1 PROJECTED COST-EFFECTIVENESS OF BIPH

✍ M Aagren; TL Thomsen; VK Knudsen 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

PDB3 COST-EFFECTIVENESS ANALYSIS OF INSU

✍ I Smith; AJ Palmer; S Roze; T Kennedy-Martin 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 82 KB

Cost-Effectiveness of Insulin Degludec C

✍ Evans, M.; Chubb, B.; Christensen, T.; Gundgaard, J.; Wolden, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB